Michigan-based digital manufacturer, Extol, Inc., announces FDA registration for contract manufacturing of 3D printed medical devices. The FDA registration will allow Extol to expand its offerings for the life-sciences industry. It will immediately impact Extol’s capability to provide complete solutions for additive manufacturing of medical devices for the orthotics and prosthetics (O&P) market.
“Digital manufacturing with 3D printing is disrupting the way people make products in nearly every industry,” says Kyle Harvey, Extol’s Business Unit Manager for Additive Manufacturing.
“Digital transformation is well underway in the O&P industry to create better outcomes for patients using the medical devices. We are very excited to support O&P partners and practitioners who are investing in digital workflows.”
Realizing the full potential of digital transformation requires a complete solution to turn 3D printed parts into a finished product. The same is true in the O&P industry. As an FDA-registered contract manufacturer, Extol will provide turnkey manufacturing solutions including printing, post-processing, final assembly, and order fulfillment of finished medical devices.
Subscribe to AM Chronicle Newsletter to stay connected: https://bit.ly/3fBZ1mP
Follow us on LinkedIn: https://bit.ly/3IjhrFq
Visit for more interesting content on additive manufacturing: https://amchronicle.com/
